Analysts think TNXP stock price could increase by 912%
Dec 24, 2024, 12:26 PM
-20.86%
What does TNXP do
Tonix Pharmaceuticals Holding, based in Chatham, New Jersey, specializes in developing therapeutics for CNS disorders and immunology, with a portfolio including TNX-102 SL for fibromyalgia and TNX-1500 for autoimmune diseases. Founded in 2010, the company employs 103 people and markets Zembrace SymTouch and Tosymra.
5 analysts think TNXP stock price will increase by 912.16%. The current median analyst target is $4.08 compared to a current stock price of $0.40. The lowest analysts target is $2.52 and the highest analyst target is $11.55.
📡️ Health Care
Price Target
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.